Literature DB >> 17560419

Extra-intestinal manifestations of Crohn's disease.

Kimberly Ephgrave1.   

Abstract

Extra-intestinal manifestations occur in at least 25% of Crohn's disease patients. Some extra-intestinal manifestations, such as erythema nodusum and peripheral arthropathy, will wax and wane in keeping with bowel inflammation. The more severe cutaneous ulcerations, uveitis, and axial arthropathy may precede bowel disease or persist after it subsides. Screening may be appropriate for eye disease and for osteoporosis to prevent complications. Medical management for extra-intestinal manifestations is similar to treatment for the bowel symptoms of Crohn's disease, with corticosteroids the mainstay. Pain and depression are associated with inflammatory bowel disease, and their control benefits patients. Recent small studies with anti-tumor necrosis factor (TNF) agents are promising for most extra-intestinal manifestations of Crohn's disease, and may permit more steroid-sparing disease control in the future.

Entities:  

Mesh:

Year:  2007        PMID: 17560419     DOI: 10.1016/j.suc.2007.03.003

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  20 in total

Review 1.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

2.  Clinical spectrum of vulva metastatic Crohn's disease.

Authors:  Susan Leu; Patricia K Sun; James Collyer; Aimee Smidt; Catherine S Stika; Bethanee Schlosser; Ginat W Mirowski; Arvydas Vanagunas; Alan L Buchman
Journal:  Dig Dis Sci       Date:  2009-05-07       Impact factor: 3.199

Review 3.  Pulmonary manifestations of Crohn's disease.

Authors:  De-Gan Lu; Xiao-Qing Ji; Xun Liu; Hong-Jia Li; Cai-Qing Zhang
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 4.  Epidemiology and clinical course of Crohn's disease: results from observational studies.

Authors:  Øistein Hovde; Bjørn A Moum
Journal:  World J Gastroenterol       Date:  2012-04-21       Impact factor: 5.742

5.  MRI of vulvar Crohn disease.

Authors:  Deepa Pai; Jonathan R Dillman; Maryam Ghadimi Mahani; Peter J Strouse; Jeremy Adler
Journal:  Pediatr Radiol       Date:  2010-11-21

Review 6.  Inflammatory bowel disease: is it a primary immunodeficiency?

Authors:  Erik Glocker; Bodo Grimbacher
Journal:  Cell Mol Life Sci       Date:  2011-10-14       Impact factor: 9.261

Review 7.  Clinical immunology review series: an approach to the patient with recurrent superficial abscesses.

Authors:  S L Johnston
Journal:  Clin Exp Immunol       Date:  2008-04-16       Impact factor: 4.330

8.  Tracheobronchial nodules and pulmonary infiltrates in a patient with Crohn's disease.

Authors:  De-Gan Lu; Xiao-Qing Ji; Qi Zhao; Cai-Qing Zhang; Zhen-Fang Li
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

9.  Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease.

Authors:  Andrew M Smith; Farooq Z Rahman; Bu'Hussain Hayee; Simon J Graham; Daniel J B Marks; Gavin W Sewell; Christine D Palmer; Jonathan Wilde; Brian M J Foxwell; Israel S Gloger; Trevor Sweeting; Mark Marsh; Ann P Walker; Stuart L Bloom; Anthony W Segal
Journal:  J Exp Med       Date:  2009-08-03       Impact factor: 14.307

Review 10.  Revisiting Crohn's disease as a primary immunodeficiency of macrophages.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  J Exp Med       Date:  2009-08-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.